Diaceutics Plc · LSE:DXRX
Diaceutics — Practice Gaps Webinar 2 (March 2023)
5 slides from Diaceutics's conference presentation, Mar 15, 2023
Slide 1: Practice Gaps Webinar 2 Q&A
Practice Gaps Webinar 2 15th March 2023 Q&A
Slide 2: Questions 1-3
Question 1 Question 2 I am assuming Do you think it’s got any better since 2019? that you are not I would say it dropped a little bit during COVID because the focus was not really on counting an H&E as testing, but it is regaining its momentum. I would say from what we’re seeing that it’s slowly get
Slide 3: Question 4
Question 4 What do you think the impact to overcome gap 4 would be of automated or reflexive biomarker test ordering for appropriate cases of aNSCLC? How can we bring forward a standard policy of reflex testing? I think moving towards both reflexive testing and also early testing at least in the bio
Slide 4: Question 5
Question 5 In this study we looked at non small I would say it’s going even be more complicated and potentially more challenging, for example, with lung cancer we already cell lung cancer and a subsegment have a lot of approved biomarkers in this indication and if more of those patients newly diagno
Slide 5: Watch the Webinar here
For more information on Practice Gaps Webinar 2 please get in contact at : marketing@diaceutics.com To watch the webinar please follow the link below : Watch the Webinar here